SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 63 of 100
Leadership
Bill Ackman Says Valeant Might Change Its Name to Fix Its Reputation
By
Reuters
November 11, 2016
Finance
Donald Trump’s Presidency Could Unleash a Pharma Merger Boom
By
Reuters
November 11, 2016
Health
Big Pharma Pulled Off Its Own Upset on Election Night
By
Sy Mukherjee
November 9, 2016
Health
Pharma Stocks Are Soaring After Donald Trump’s Victory
By
Reuters
and
Fortune Editors
November 9, 2016
Tech
Walgreens Sues Theranos for $140 Million for Breach of Contract
By
Kia Kokalitcheva
November 8, 2016
Health
This Bipartisan Group of Senators Is Asking Mylan to Reimburse the Military
By
Reuters
November 8, 2016
Health
These Pharma Stocks Plunged on Reports of Pending Price Collusion Charges
By
Reuters
November 4, 2016
Health
Federal Prosecutors Reportedly Plan Major Price Fixing Suit Against Drug Makers
By
Sy Mukherjee
November 3, 2016
Health
Valeant Is Being Sued Over the ‘Female Viagra’ Pill
By
Reuters
and
Tekendra Parmar
November 3, 2016
Finance
Why Express Scripts CMO Thinks Drug Price Regulation Is a “Bad Idea”
By
Jen Wieczner
November 2, 2016
Health
How Drug Development Cycles May Be ‘Getting Smaller and Smaller’
By
Kia Kokalitcheva
November 2, 2016
Finance
Here’s Why Valeant Selling Salix Was a Huge Surprise to the Stock Market
By
Jen Wieczner
November 2, 2016
Health
Mylan’s EpiPen Price Hikes Reportedly Add Millions to Pentagon Costs
By
Reuters
and
Michelle Toh
October 28, 2016
Finance
Bayer Beats Expectations with a Payoff in Profits
By
Reuters
and
Michelle Toh
October 26, 2016
Health
This Could Be the Next Blockbuster Drug for GlaxoSmithKline
By
Reuters
October 24, 2016
Most Popular
Economy
Jerome Powell says the Gen Z hiring nightmare is real: 'Kids coming out of college...are having a hard time finding...
By
Nick Lichtenberg
Banking
Markets expected the rate cut, but the ‘real surprise’ is the Fed’s opinion on the current state of the economy, quant...
By
Amanda Gerut
Economy
Starbucks CEO says the coffee chain won't lose its cash-strapped consumers because it's on its way to being a...
By
Sasha Rogelberg